64372-56-1,
Citalopram related compound A [USP],
Citalopram hydrobromide impurity A [EP],
Citalopram hydrochloride impurity A [EP],
Escitalopram EP Impurity A,
SCHEMBL2869030,
CHEMBL3094183,
SCHEMBL10038948,
AKOS025401907,
(+/-)-1-(3-Dimethylaminopropyl)-1-(4'-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide,
1-(3-Dimethylaminopropyl)-1-(4'-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide,
1-(3-Dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide,
5-Isobenzofurancarboxamide, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-,
AC-27037,
A1-06478,
1-(3-Dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydro-isobenzofuran-5 -carboxamide,
1-(4-Fluorophenyl)-1-[3-(dimethylamino)propyl]-1,3-dihydroisobenzofuran-5-carboxamide,
1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarboxamide,
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carboxamide,
(1RS)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide,
(1RS)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide (Citalopram-Amide),
UNII-BP83XJ2B6A,
Citalopram EP Impurity A,
BP83XJ2B6A,
Citalopram related compound A,
USP Citalopram Related Compound A,
CS-O-07652,
CID10193515,
1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-3H-isobenzofuran-5-carboxamide,